25-27
Aug
2026
CPHI Korea 2026
COEX, Seoul, Korea
N35
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
16K17

Olive Healthcare

About Olive Healthcare

Olive PharmaScience Limited (India)

Olive PharmaScience is an Exclusive Developer & Manufacturer of Soft Gel formulations, located in India, primarily engaged in Out-Licensing of self developed Dossiers in addition to select CDMO Projects.


Major Regulatory Approvals:  WHO, US FDA, EU GMP, TGA, Russia, Brazil, Colombia, Saudi Arabia, UAE, Jordan, Iraq, Syria et al.

Product Categories: Generics, OTC's, High-Potency Molecules, Hormones, Oncology, Immunosuppressants, Nutritional Supplements et al.


By 2026, Olive will commission a GMP Approved Site for Gummies (Nutritional & Pharma OTC) in India.

Certifications

Meet us at

  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Contact info
  • Regd. Office: Godrej Colisuem, Somaiya Hospital Road, B-3, 2nd Floor, Sion (East), 400 022, Mumbai, India

Products from Olive Healthcare (37)